| Name | Title | Contact Details |
|---|
Munson Healthcare is northern Michigan`s largest and leading health care system. Based in Traverse City, Mich., our team of medical experts, nine award-winning community hospitals, and related organizations serve people in 30 counties. Most of the region`s 540,000 residents can receive comprehensive quality care in or near their local community with access to sophisticated diagnostic technology such as 3D tomography, advanced cancer and heart treatments, and the latest robotic technology, stereotactic radiosurgery, and non-invasive surgical procedures. Patients in northern Michigan also benefit from Munson Healthcare`s collaborative partnerships with major health care systems, including Mayo Clinic, Michigan Medicine, Spectrum Health, and Mary Free Bed Rehabilitation Hospital.
Cornerstone Specialty Network is a company that provides value to community-based oncology practices through network aggregation, delivering value-added opportunities that support independence and long-term sustainability for community oncology practices.
Worldwide provider and innovator in the fields of wellness, beauty, rejuvenation and transformation across the globe at sea on cruise ships and on land.
At PolyNovo we are driven by improving the outcomes of patients through development and provision of the best surgical solutions possible. PolyNovo develops innovative medical devices utilizing the patented bioabsorbable polymer technology Novosorb®. NovoSorb is a family of proprietary medical grade polymers that can be expressed in a variety of physical formats. NovoSorb polymers have advantageous properties such as biocompatibility and design flexibility. These properties underpin novel medical devices designed to support tissue repair, before they biodegrade in situ into biocompatible by-products via established pathways. NovoSorb BTM (Biodegradable Temporizing Matrix) is the first product commercialized by PolyNovo. In 2015, following the FDA 510(K) clearance of BTM, PolyNovo was awarded an $11 million contract and a further $25 million in funding from the US-based Biomedical Advanced Research and Development Authority (BARDA) to complete a trial with BTM for full thickness burns. We have expanded our manufacturing facility and headquarters in Melbourne, Australia, establishing high quality processes, enabling product innovation and preparing for growth.
Tulare Cnty Alcoholism Council is a Visalia, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.